S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.

S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.

Item
http://www.wikidata.org/entity/Q38660442
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathwayA randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.Chemotherapy for advanced gastric cancer.New agents on the horizon in gastric cancer.Chemotherapy for advanced gastric cancer: future perspective in Japan.The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancerChemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases.Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion.Current therapeutic landscape for advanced gastroesophageal cancers.Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer.miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer
P2860

S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.

Item
http://www.wikidata.org/entity/Q38660442
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
S-1 plus leucovorin versus S-1 ...... re, open-label, phase 2 trial.
@en
type
label
S-1 plus leucovorin versus S-1 ...... re, open-label, phase 2 trial.
@en
prefLabel
S-1 plus leucovorin versus S-1 ...... re, open-label, phase 2 trial.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
S-1 plus leucovorin versus S-1 ...... re, open-label, phase 2 trial.
@en
P2093
P304
P31
P356
10.1016/S1470-2045(15)00410-6
P433
P478
P577
P5875
P698
P921